Skip to main content
padlock icon - secure page this page is secure

Nanoparticulate Contrast Agents for Multimodality Molecular Imaging

Buy Article:

$106.34 + tax (Refund Policy)

Molecular imaging is rapidly developing as a powerful tool in research and medical diagnostic. By integrating complementary signal reporters into a single nanoparticulate contrast agent, multimodal molecular imaging can be performed as scalable images with high sensitivity, resolution and specificity. In this review, multifunctional nanoparticles (MFNPs) are classified into four types: conjugation, encapsulation, core/shell, and co-doping. Further, new constructs of MFNPs were reported recently which have used nanoparticulate contrast agent such as quantum dots (QDs), iron oxide nanoparticles (IONPs), Upconversion nanoparticles (UCNPs), carbon based nanoparticles, gold nanoparticles (Au-NPs), Metal-Organic Frameworks (MOFs), dendrimers and porphyrins based nanoparticles. Different surface modification strategies were also developed as well as ligands are attached to those NPs to render the biocompatibility and enable specific targeting. These new development in MFNPs are expected to introduce a paradigm shift in multi-modal molecular imaging and thereby opening up an era of personalized medicine and new diagnostic medical imaging tools.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Review Article

Publication date: August 1, 2016

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more